Ethylene Oxide Attorney in Erie, Pennsylvania

Cosmed Group's Multi-Facility Pattern and Trump Exemption

Cosmed Group operates EtO sterilization facilities in multiple states, with the Erie facility being one of the company's largest operations. The Trump administration's decision to exempt Cosmed's Erie facility from the 2024 EPA NESHAP emission rules means the company is not required to install the enhanced pollution controls — scrubbers, enclosures, and monitoring systems — that other facilities must adopt. For Erie residents, this means continued exposure to EtO emissions at levels that the EPA itself determined were unacceptably dangerous when it finalized the 2024 rules.

The exemption decision creates a powerful narrative for plaintiffs: the federal government determined in 2024 that existing emission levels from facilities like Cosmed's were unsafe and required 90%+ reductions, but the Trump administration overrode that determination for political reasons. Plaintiffs can argue that the 2024 NESHAP rule constitutes an admission by the EPA that pre-rule emission levels — the levels Erie residents have been exposed to for years — cause unacceptable cancer risk.

Pennsylvania Medical Monitoring: A Pre-Diagnosis Legal Avenue

Pennsylvania is one of the few states that explicitly recognizes medical monitoring as an independent cause of action for toxic exposure. Under the Pennsylvania Supreme Court's ruling in Redland Soccer Club v. Department of the Army, individuals who have been exposed to a proven carcinogen can sue for the cost of ongoing medical surveillance even before they develop cancer. This is critically important for Erie residents near the Cosmed facility who have been exposed to EtO but have not yet been diagnosed with cancer.

A medical monitoring claim requires showing: (1) exposure to a proven hazardous substance, (2) caused by the defendant's negligence, (3) resulting in a significantly increased risk of disease, (4) for which medical monitoring is reasonably necessary. For Erie residents living near the Cosmed facility, each element is supportable through EPA data, EtO's IARC Group 1 carcinogen classification, and medical expert testimony. Medical monitoring claims can fund years of cancer screening — CT scans, blood panels, and specialist visits — that catch EtO-linked cancers at their earliest and most treatable stages.